Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 2 (2007), Issue 12 (December)

1. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection.
   Gastroenterology, 133(6): 1821-30. [Abstract] [Full-text]
2. Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada.
   Int J Cancer, 122(3): 630-3. [Abstract] [Full-text]
3. Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient.
   Virology, 370(2): 237-45. [Abstract] [Full-text]
4. Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
   J Virol, 82(1): 435-50. [Abstract] [Full-text]
5. Mutations in the interferon sensitivity-determining region (nonstructural 5A amino acid 2209-2248) in patients with hepatitis C-1b infection and correlating response to combined therapy of pegylated interferon and ribavirin.
   Aliment Pharmacol Ther, 27(1): 72-9. [Abstract] [Full-text]
6. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
   Aliment Pharmacol Ther, 27(1): 80-9. [Abstract] [Full-text]
7. Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan.
   Lancet, 370(9604): 2063-7. [Abstract] [Full-text]
8. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
   Oncology, 72: 132-8. [Abstract] [Full-text]
9. Long-term effects of interferon-based therapy for chronic hepatitis C.
   Oncology, 72: 16-23. [Abstract] [Full-text]
10. Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.
    AIDS, 22(1): 152-4. [Abstract] [Full-text]
11. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    AIDS, 22(1): 15-21. [Abstract] [Full-text]
12. NS5ATP9, a gene up-regulated by HCV NS5A protein.
    Cancer Lett, 259(2): 192-7. [Abstract] [Full-text]
13. Telbivudine versus lamivudine in patients with chronic hepatitis B.
    N Engl J Med, 357(25): 2576-88. [Abstract] [Full-text]
14. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years.
    Gut, 57(1): 84-90. [Abstract] [Full-text]
15. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Gut, 57(1): 91-7. [Abstract] [Full-text]
16. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    AIDS, 22(2): 203-10. [Abstract] [Full-text]
17. Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and staging.
    Abdom Imaging, 33(1): 58-64. [Abstract] [Full-text]
18. Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review.
    Am J Health Syst Pharm, 65(1): 37-41. [Abstract] [Full-text]
19. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France.
    J Med Virol, 80(2): 289-93. [Abstract] [Full-text]
20. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
    J Med Virol, 80(2): 254-60. [Abstract] [Full-text]
21. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    J Med Virol, 80(2): 247-53. [Abstract] [Full-text]
22. Transmission of low-density hepatitis C viral particles during sexually transmitted acute resolving infection.
    J Med Virol, 80(2): 242-6. [Abstract] [Full-text]
23. The increasing prevalence of hepatitis delta virus (HDV) infection in South London.
    J Med Virol, 80(2): 277-82. [Abstract] [Full-text]
24. Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: time for routine testing?
    J Med Virol, 80(2): 283-8. [Abstract] [Full-text]
25. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    J Med Virol, 80(2): 268-76. [Abstract] [Full-text]
26. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit in Italy.
    J Med Virol, 80(2): 261-7. [Abstract] [Full-text]
27. Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences.
    J Med Virol, 80(2): 233-41. [Abstract] [Full-text]
28. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    J Med Virol, 80(2): 225-32. [Abstract] [Full-text]
29. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan.
    J Med Virol, 80(2): 217-24. [Abstract] [Full-text]
30. Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis.
    J Pediatr Gastroenterol Nutr, 46(1): 65-70. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.